CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
| Pennsylvania | 1-31070 | 23-2328753 |
| (State or other jurisdiction | (Commission | (IRS employer |
| of incorporation) | File Number) | identification number) |
Derma Sciences, Inc. (the “Registrant”) on June 11, 2003 concluded a private offering of its common stock. Pursuant to the offering, 4,000,000 shares of common stock were sold at $0.50 per share for total offering proceeds of $2,000,000. The Registrant will utilize the offering proceeds for working capital and to fund strategic initiatives. The Registrant has agreed to file a registration statement with the Securities and Exchange Commission relative to the shares of common stock sold in the offering.
The foregoing sales of common stock and offering proceeds are inclusive of the sales and proceeds relative to the offering previously reported by the Registrant on Form 8-K and Form 8-K/A-1 filed with the Securities and Exchange Commission March 6, 2002 and June 6, 2002, respectively. The Purchase Agreement, Registration Rights Agreement and Legal Opinion relative to the offering are attached hereto as Exhibits 10.01, 10.02 and 10.03, respectively.
| (a) Not applicable | |
| (b) Not applicable | |
| (c) Exhibits: |
| 10.01 | - Purchase Agreement | |
| 10.02 | - Registration Rights Agreement | |
| 10.03 | - Legal Opinion |
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| DERMA SCIENCES, INC. | ||
| Date: June 11, 2003 | By: /s/ John E. Yetter John E. Yetter, CPA Vice President and Chief Financial Officer |
3